Author/Creator: Kale, Hrishikesh - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kale, Hrishikesh

1. 354 Trends in the Drug-Sparing Effects for Benzodiazepines and Prescription Opioids among Insomnia Patients on Suvorexant in the US. (3rd May 2021)

Authors:: Kale, Hrishikesh; Khandker, Rezaul; Shah, Ruchit; Botteman, Marc; Meng, Weilin; Jootun, Murvin; Qureshi, Zaina
Journal:: Sleep
Issue:: Volume 44(2021)Supplement 2
Page Start:: A141
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Can routine MRI spine T1 sequences be used for prediction of decreased bone density?. (January 2023)

Authors:: Kale, Hrishikesh; Yadav, Saksham
Journal:: Acta radiologica
Issue:: Volume 64:Number 1(2023)
Page Start:: 164
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended‐release oxycodone with abuse‐deterrent characteristics. (30th September 2013)

Authors:: Coplan, Paul M.; Kale, Hrishikesh; Sandstrom, Lauren; Landau, Craig; Chilcoat, Howard D.
Journal:: Pharmacoepidemiology and drug safety
Issue:: Volume 22:Number 12(2013:Dec.)
Page Start:: 1274
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Epidural Contrast Volume on Post‐Myelogram Lumbar CT Predicts the Rate of Subsequent Blood Patch Treatment. Issue 4 (20th April 2021)

Authors:: Yu, Robinson; Kale, Hrishikesh; Branstetter, Barton F.; Palfey, Stacie; Agarwal, Vikas
Journal:: Journal of neuroimaging
Issue:: Volume 31:Issue 4(2021)
Page Start:: 691
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Physician referral patterns and use of adjuvant therapy among patients with stage IB-IIIA non–small cell lung cancer (NSCLC) (2010-2017). Issue 28 (1st October 2022)

Authors:: Kale, Hrishikesh; Wang, Wei-Jhih; Chirikov, Viktor; Shah, Anne; Apple, Jon
Journal:: Journal of clinical oncology
Issue:: Volume 40:Issue 28(2022)Supplement
Page Start:: 114
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation†. (11th June 2014)

Authors:: Sessler, Nelson E.; Downing, Jerod M.; Kale, Hrishikesh; Chilcoat, Howard D.; Baumgartner, Todd F.; Coplan, Paul M.
Journal:: Pharmacoepidemiology and drug safety
Issue:: Volume 23:Number 12(2014:Dec.)
Page Start:: 1238
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Routes of administration and frequency of abuse of OxyContin® and immediate-release oxycodone in a rural kentucky county following introduction of reformulated OxyContin: Results from the first 71 follow-up interviews. (1st January 2015)

Authors:: Havens, Jennifer R.; DeVeaugh-Geiss, Angela; Leukefeld, Carl; Kale, Hrishikesh; Coplan, Paul; Chilcoat, Howard
Journal:: Drug and alcohol dependence
Issue:: Volume 146(2015)
Page Start:: e138
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗